新規理学療法ジャーナル

抽象的な

The Regulatory Action of Fibro fog: Pain, Quality of Life, Sleep, Anxiety and Depression observed after 42 Months of Treatment: A Case Report

Laser; Ultrasound; Sleep; Fibro fog; Anxiey; Depression

Fibromyalgia is a chronic syndrome that acts on the musculoskeletal system, causing disabling pain, in addition to many other symptoms. As one of the associated symptoms, there are cognitive changes, such as difficulty maintaining concentration and memory, known as Fibrofog. The difficulties imposed by cognitive dysfunctions can change the lives of patients with fibromyalgia, affecting family, professional life and social interaction. As a treatment for fibromyalgia, the combined use of laser and ultrasound has been of great value, reducing pain and improving quality of life. The present study followed a patient affected by fibromyalgia for 42 months after treatment with laser and ultrasound, quantifying questionnaires and scales: Visual Analogue Scale, Fibromyalgia Impact Questionnaire, Pittsburgh Sleep Quality Index, Hospital Anxiety and Depression Scale and Beck Depression Inventory – II. The results point to a reduction of over 90% for the improvement of the evaluated conditions of pain, quality of life, sleep, anxiety and depression, ending with the report of improvement in Fibrofog, where the patient, after treatment, started her graduation in physiotherapy. We conclude that the methodology employed, using the synergism of Laser and ultrasound, although it points to the improvement of Fibrofog in a case report, is widely used in the treatment of fibromyalgia for pain control, allowing new follow-ups to be carried out.